GreenLight Biosciences Holdings, PBC Debt to Equity Ratio 2021-2023 | GRNA
Current and historical debt to equity ratio values for GreenLight Biosciences Holdings, PBC (GRNA) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. GreenLight Biosciences Holdings, PBC debt/equity for the three months ending March 31, 2023 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2023-03-31 | $0.09B | $0.02B | 4.18 |
| 2022-12-31 | $0.10B | $0.05B | 2.09 |
| 2022-09-30 | $0.07B | $0.08B | 0.79 |
| 2022-06-30 | $0.09B | $0.01B | 6.20 |
| 2022-03-31 | $0.06B | $0.06B | 0.92 |
| 2021-12-31 | $0.09B | $-0.03B | -3.10 |
| 2021-09-30 | $0.22B | $-0.02B | -13.90 |
| 2021-06-30 | $0.20B | $0.01B | 40.59 |
| 2021-03-31 | $0.20B | $0.01B | 40.63 |
| 2020-12-31 | $0.00B | 0.00 | |
| 2020-09-30 | $0.00B | $0.00B | 6.10 |
